The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Humacyte, Inc.(NASDAQ:HUMA) 
Humacyte, Inc., a clinical-stage biotechnology platform company, develops and manufactures off-the-shelf bioengineered human tissues. The company develops and manufactures acellular tissues to address life- and limb-threatening vascular conditions for complex organ disease. Its Human Acellular Vesse...
Share this website to your friends
Humacyte . Days Payable Outstanding ttm (DPO)
Humacyte . Op Cashflow Per Share ttm
Humacyte . Free Cashflow Per Share ttm
Humacyte . Cash Per Share ttm
Humacyte . (GAAP) P/E ratio ttm
Humacyte . P/B ratio ttm
No extra charts and metrics for this ticker.